{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:04:43Z","timestamp":1789236283972,"version":"build-2803163510"},"reference-count":34,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2022,8,1]]},"DOI":"10.3724\/abbs.2022114","type":"journal-article","created":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T22:12:50Z","timestamp":1660515170000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":6,"title":["MOR promotes epithelial-mesenchymal transition and proliferation via PI3K\/AKT signaling pathway in human colorectal cancer"],"prefix":"10.3724","author":[{"given":"Lingling","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/bja\/aeq164","volume":"105","author":"Snyder GL","year":"2010","unstructured":"Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesthesia, 2010, 105: 106-115.","journal-title":"Br J Anaesthesia"},{"key":"CITATION2","unstructured":"Kaye AD, Patel N, Bueno FR, Hymel B, Vadivelu N, Kodumudi G, Urman RD. Effect of opiates, anesthetic techniques, and other perioperative factors on surgical cancer patients. Ochsner J 2014, 14: 216\u2013228."},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1213\/ANE.0000000000001652","volume":"124","author":"Sekandarzad MW","year":"2017","unstructured":"Sekandarzad MW, van Zundert AA, Lirk PB, Doornebal CW, Hollmann MW. Perioperative anesthesia care and tumor progression. Anesth Analg, 2017, 124: 1697-1708.","journal-title":"Anesth Analg"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1213\/ANE.0b013e3181d8d183","volume":"110","author":"Bovill JG","year":"2010","unstructured":"Bovill JG. Surgery for cancer. Anesth Analg, 2010, 110: 1524-1526.","journal-title":"Anesth Analg"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/00000542-200610000-00008","volume":"105","author":"Exadaktylos AK","year":"2006","unstructured":"Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?. Anesthesiology, 2006, 105: 660-664.","journal-title":"Anesthesiology"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1213\/ane.0b013e3181770f55","volume":"107","author":"Christopherson R","year":"2008","unstructured":"Christopherson R, James KE, Tableman M, Marshall P, Johnson FE. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg, 2008, 107: 325-332.","journal-title":"Anesth Analg"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/bja\/aer055","volume":"106","author":"Lin L","year":"2011","unstructured":"Lin L, Liu C, Tan H, Ouyang H, Zhang Y, Zeng W. Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis. Br J Anaesthesia, 2011, 106: 814-822.","journal-title":"Br J Anaesthesia"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/ALN.0b013e31817f5b73","volume":"109","author":"Biki B","year":"2008","unstructured":"Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence. Anesthesiology, 2008, 109: 180-187.","journal-title":"Anesthesiology"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/ijc.26448","volume":"130","author":"Tavare AN","year":"2012","unstructured":"Tavare AN, Perry NJS, Benzonana LL, Takata M, Ma D. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents*. Int J Cancer, 2012, 130: 1237-1250.","journal-title":"Int J Cancer"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/bja\/aeu090","volume":"113","author":"Nguyen J","year":"2014","unstructured":"Nguyen J, Luk K, Vang D, Soto W, Vincent L, Robiner S, Saavedra R. Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer. Br J Anaesthesia, 2014, 113: i4-i13.","journal-title":"Br J Anaesthesia"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"Siegel RL","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin, 2019, 69: 7-34.","journal-title":"CA Cancer J Clin"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","volume":"103","author":"Ferlay J","year":"2018","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer, 2018, 103: 356-387.","journal-title":"Eur J Cancer"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11864-019-0699-1","volume":"21","author":"Szczepaniak A","year":"2020","unstructured":"Szczepaniak A, Fichna J, Zieli\u0144ska M. Opioids in cancer development, progression and metastasis: focus on colorectal cancer. Curr Treat Options Oncol, 2020, 21:","journal-title":"Curr Treat Options Oncol"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12029-018-0086-3","volume":"49","author":"Alzaidi MA","year":"2018","unstructured":"Alzaidi MA, Arab HA, Amanpour S, Shirkoohi R, Muhammadnejad S, Sasani F. Author correction: opium consumption and the incidence of cancer: does opium account as an emerging risk factor for gastrointestinal cancer?. J Gastrointest Canc, 2018, 49:","journal-title":"J Gastrointest Canc"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","volume":"11","author":"Trescot Md AM","year":"2008","unstructured":"Trescot Md AM. March 2008. Pain Phys, 2008, 11: S133-S153.","journal-title":"Pain Phys"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"PL461","DOI":"10.1016\/0024-3205(94)00533-8","volume":"55","author":"Zadina JE","year":"1994","unstructured":"Zadina JE, Kastin AJ, Ge LJ, Hackler L. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs. Life Sci, 1994, 55: PL461-PL466.","journal-title":"Life Sci"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/j.bja.2018.09.030","volume":"122","author":"Chen DT","year":"2019","unstructured":"Chen DT, Pan JH, Chen YH, Xing W, Yan Y, Yuan YF, Zeng WA. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target. Br J Anaesthesia, 2019, 122: e157-e167.","journal-title":"Br J Anaesthesia"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/ALN.0b013e31824babe2","volume":"116","author":"Lennon FE","year":"2012","unstructured":"Lennon FE, Mirzapoiazova T, Mambetsariev B, Salgia R, Moss J, Singleton PA. Overexpression of the \u03bc-opioid receptor in human non-small cell lung cancer promotes akt and mTOR activation, tumor growth, and metastasis. Anesthesiology, 2012, 116: 857-867.","journal-title":"Anesthesiology"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-011-9285-0","volume":"30","author":"Afsharimani B","year":"2011","unstructured":"Afsharimani B, Cabot P, Parat MO. Morphine and tumor growth and metastasis. Cancer Metastasis Rev, 2011, 30: 225-238.","journal-title":"Cancer Metastasis Rev"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10620-007-9897-y","volume":"53","author":"Nylund G","year":"2008","unstructured":"Nylund G, Pettersson A, Bengtsson C, Khorram-Manesh A, Nordgren S, Delbro DS. Functional expression of \u03bc-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon. Dig Dis Sci, 2008, 53: 461-466.","journal-title":"Dig Dis Sci"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00432-010-0816-9","volume":"136","author":"Shen Z","year":"2010","unstructured":"Shen Z, Zhou S, Wang Y, Li R, Zhong C, Liang C, Sun Y. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+\/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol, 2010, 136: 1585-1595.","journal-title":"J Cancer Res Clin Oncol"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ALN.0b013e3181a913e1","volume":"111","author":"Sessler DI","year":"2009","unstructured":"Sessler DI. Long-term consequences of anesthetic management. Anesthesiology, 2009, 111: 1-4.","journal-title":"Anesthesiology"},{"key":"CITATION23","unstructured":"Tzoneva D, Cherkezov J and Georgiev S, Masljankov S, Todorov G. Long-term consequences of anesthetic technique after cancer surgery. Khirurgiia (Sofiia) 2014: 69-74."},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.bpa.2019.07.004","volume":"33","author":"Sen S","year":"2019","unstructured":"Sen S, Koyyalamudi V, Smith DD, Weis RA, Molloy M, Spence AL, Kaye AJ. The role of regional anesthesia in the propagation of cancer: a comprehensive review. Best Pract Res Clin Anaesthesiology, 2019, 33: 507-522.","journal-title":"Best Pract Res Clin Anaesthesiology"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/AAP.0b013e3181fa11a9","volume":"35","author":"Yeager MP","year":"2010","unstructured":"Yeager MP, Rosenkranz KM. Cancer recurrence after surgery. Regional Anesth Pain Med, 2010, 35: 483-484.","journal-title":"Regional Anesth Pain Med"},{"key":"CITATION26","unstructured":"Gupta K, Kshirsagar S and Chang L, Schwartz R, Law PY, Yee D, Hebbel RP. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 2002, 62: 4491-4498."},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/jpr.s4748","author":"Leo S","year":"2009","unstructured":"Leo S, Nuydens R, Meert TF. Opioid-induced proliferation of vascular endothelial cells. JPR, 2009,","journal-title":"JPR"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/bf02071128","volume":"15","author":"Kieffer BL","year":"1995","unstructured":"Kieffer BL. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol Neurobiol, 1995, 15: 615-635.","journal-title":"Cell Mol Neurobiol"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/bph.12612","volume":"172","author":"Cox BM","year":"2015","unstructured":"Cox BM, Christie MJ, Devi L, Toll L, Traynor JR. Challenges for opioid receptor nomenclature: IUPHAR review 9. Br J Pharmacol, 2015, 172: 317-323.","journal-title":"Br J Pharmacol"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1213\/ANE.0b013e31820568af","volume":"112","author":"Mathew B","year":"2011","unstructured":"Mathew B, Lennon FE, Siegler J, Mirzapoiazova T, Mambetsariev N, Sammani S, Gerhold LM. The novel role of the mu opioid receptor in lung cancer progression. Anesth Analg, 2011, 112: 558-567.","journal-title":"Anesth Analg"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/dote.12165","volume":"28","author":"Zhang YF","year":"2015","unstructured":"Zhang YF, Xu QX, Liao LD, Xu XE, Wu JY, Wu ZY, Shen JH. Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma. Dis Esophagus, 2015, 28: 196-203.","journal-title":"Dis Esophagus"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/1097-0282(2000)55:4<334::AID-BIP1006>3.0.CO;2-S","volume":"55","author":"Chaturvedi K","year":"2000","unstructured":"Chaturvedi K, Christoffers KH, Singh K, Howells RD. Structure and regulation of opioid receptors. Biopolymers, 2000, 55: 334-346.","journal-title":"Biopolymers"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"772","DOI":"10.2174\/092986708783955518","volume":"15","author":"Chen YL","year":"2008","unstructured":"Chen YL, Law PY, Loh HH. The other side of the opioid story: modulation of cell growth and survival signaling. Curr Med Chem, 2008, 15: 772-778.","journal-title":"Curr Med Chem"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbcan.2009.03.002","volume":"1796","author":"Voulgari A","year":"2009","unstructured":"Voulgari A, Pintzas A. Epithelial\u2013mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta (BBA) - Rev Cancer, 2009, 1796: 75-90.","journal-title":"Biochim Biophys Acta (BBA) - Rev Cancer"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/2C53943C21024A078A4C92ADDFE0ADC7","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2022114","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/2C53943C21024A078A4C92ADDFE0ADC7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T23:34:04Z","timestamp":1660779244000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2022114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3724\/abbs.2022114","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}